Executive dysfunction in chronic cocaine users: An exploratory study

Drug and Alcohol Dependence

Volumn 117, Issue 1, 2011, Pages 55-58

  Madoz Gúrpide, Agustín ^a   Blasco Fontecilla, Hilario ^b   Baca García, Enrique ^b,c   Ochoa Mangado, Enriqueta ^d  

^a San Blas Mental Health Center   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Cocaine use; Ecological test; Executive functioning

Indexed keywords

COCAINE;

ADULT; AGED; ANALYTICAL ERROR; ARTICLE; ATTENTION; BRAIN DYSFUNCTION; CHI SQUARE TEST; COCAINE DEPENDENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXPLORATORY RESEARCH; FEMALE; FUNCTIONAL STATUS; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGIC TEST; STUDENT T TEST; TASK PERFORMANCE; TREATMENT FAILURE; WISCONSIN CARD SORTING TEST; WORKING MEMORY;

ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; COCAINE-RELATED DISORDERS; COGNITION DISORDERS; CONTROL GROUPS; DISEASE PROGRESSION; DOPAMINE UPTAKE INHIBITORS; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79959669103     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.11.030     Document Type: Article

References (49)

1. Aharonovich E., Nunes E., Hasin D. Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend. 2003, 71:207-211.
2. Ardila A., Rosselli M., Strumwasser S. Neuropsychological deficits in chronic cocaine abusers. Int. J. Neurosci. 1991, 57:73-79.
3. Barry D., Petry N.M. Predictors of decision-making on the Iowa gambling task: independent effects of lifetime history of substance use disorders and performance on the trail making test. Brain Cogn. 2008, 66:243-252.
4. Block R.I., Erwin W.J., Ghoneim M.M. Chronic drug use and cognitive impairments. Pharmacol. Biochem. Behav. 2002, 73:491-504.
5. Bolla K.I., Eldreth D.A., London E.D., Kiehl K.A., Mouratidis M., Contoreggi C., Matochik J.A., Kurian V., Cadet J.L., Kimes A.S., Funderburk F.R., Ernst M. Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage 2003, 19:1085-1094.
6. Bolla K.I., Funderburk F.R., Cadet J.L. Differential effects of cocaine and cocaine alcohol on neurocognitive performance. Neurology 2000, 54:2285-2292.
7. Bolla K.I., Rothman R., Cadet J.L. Dose-related neurobehavioral effects of chronic cocaine use. J. Neuropsychiatry Clin. Neurosci. 1999, 11:361-369.
8. Colzato L.S., van den Wildenberg W.P., Hommel B. Impaired inhibitory control in recreational cocaine users. PLoS One 2007, 2:e1143.
9. Compton W.M., Thomas Y.F., Stinson F.S., Grant B.F. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 2007, 64:566-576.
10. Corrigan J.D., Hinkeldey N.S. Relationships between parts A and B of the trail making test. J. Clin. Psychol. 1987, 43(4):402-409.
11. Cunha P.J., Nicastri S., Gomes L.P., Moino R.M., Peluso M.A. Neuropsychological impairments in crack cocaine-dependent inpatients: preliminary findings. Rev. Bras. Psiquiatr. 2004, 26:103-106.
12. Chou L.N., Kuo P.H., Lin C.C., Chen W.J. Genetic and environmental influences on the Wisconsin card sorting test performance in healthy adolescents: a twin/sibling study. Behav. Genet. 2010, 40(1):22-30.
13. Di Sclafani V., Tolou-Shams M., Price L.J., Fein G. Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug Alcohol Depend. 2002, 66:161-171.
14. EMCDDA European Monitoring Centre for Drugs and Drug Addiction: 2007 Annual Report. The State of the Drugs Problem in Europe 2007, Office for Official Publications of the European Communities, Luxemburg.
15. Ersche K.D., Roiser J.P., Robbins T.W., Sahakian B.J. Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans. Psychopharmacology (Berl) 2008, 197:421-431.
16. Feldstein S.N., Keller F.R., Portman R.E., Durham R.L., Klebe K.J., Davis H.P. A comparison of computerized and standard versions of the Wisconsin card sorting test. Clin. Neuropsychol. 1999, 13:303-313.
17. Fernández-Serrano M.J., Pérez-García M., Verdejo-García A. What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance?. Neurosci. Biobehav. Rev. 2010, [Epub ahead of print].
18. Fillmore M.T., Rush C.R. Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend. 2002, 66:265-273.
19. Fortuny L.A., Heaton R.K. Standard versus computerized administration of the Wisconsin card sorting test. Clin. Neuropsychol. 1996, 10(4):419-424.
20. Franken I.H., van Strien J.W., Franzek E.J., van de Wetering B.J. Error-processing deficits in patients with cocaine dependence. Biol. Psychol. 2007, 75:45-51.
21. Goldstein R.Z., Leskovjan A.C., Hoff A.L., Hitzemann R., Bashan F., Khalsa S.S., Wang G.J., Fowler J.S., Volkow N.D. Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex. Neuropsychologia 2004, 42:1447-1458.
22. Goldstein R.Z., Alia-Klein N., Tomasi D., Zhang L., Cottone L.A., Maloney T., Telang F., Caparelli E.C., Chang L., Ernst T., Samaras D., Squires N.K., Volkow N.D. Is decreased prefrontal cortical sensitivity to monetary reward associated with impaired motivation and self-control in cocaine addiction?. Am. J. Psychiatry 2007, 164:43-51.
23. Goldstein R.Z., Tomasi D., Alia-Klein N., Zhang L., Telang F., Volkow N.D. The effect of practice on a sustained attention task in cocaine abusers. Neuroimage 2007, 35:194-206.
24. Goldstein R.Z., Volkow N.D. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am. J. Psychiatry 2002, 159:1642-1652.
25. Hester R., Dixon V., Garavan H. A consistent attentional bias for drug-related material in active cocaine users across word and picture versions of the emotional Stroop task. Drug Alcohol Depend. 2006, 81:251-257.
26. Hester R., Simoes-Franklin C., Garavan H. Post-error behavior in active cocaine users: poor awareness of errors in the presence of intact performance adjustments. Neuropsychopharmacology 2007, 32:1974-1984.
27. Horner M.D. Attentional functioning in abstinent cocaine abusers. Drug Alcohol Depend. 1999, 54:19-33.
28. Jovanovski D., Erb S., Zakzanis K.K. Neurocognitive deficits in cocaine users: a quantitative review of the evidence. J. Clin. Exp. Neuropsychol. 2005, 27:189-204.
29. Kamei S., Hara M., Serizawa K., Murakami M., Mizutani T., Ishiburo M., Kawahara R., Takagi Y., Ogawa K., Yoshihashi H., Shinbo S., Suzuki Y., Yamaguchi M., Morita A., Takeshita J., Hirayanagi K. Executive dysfunction using behavioral assessment of the dysexecutive syndrome in Parkinson's disease. Mov. Disord. 2008, 23:566-573.
30. Lezak M.D., Howieson D.B., Loring D.W. Neuropsychological Assessment 2004, Oxford University Press, NY.
31. Lundqvist T. Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol. Biochem. Behav. 2005, 81:319-330.
32. Madoz-Gúrpide A., Ochoa Mangado E., Martinez Pelegrin B. Use of cocaine and neuropsychological damage. Clinical implications. Med. Clin. 2009, 132:555-559.
33. Majewska M.D. Cocaine addiction as a neurological disorder: implications for treatment. NIDA Res. Monogr. 1996, 163:1-26.
34. Mintzer M.Z., Stitzer M.L. Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend. 2002, 67:41-51.
35. Pace-Schott E.F., Stickgold R., Muzur A., Wigren P.E., Ward A.S., Hart C.L., Walker M., Edgar C., Hobson J.A. Cognitive performance by humans during a smoked cocaine binge-abstinence cycle. Am. J. Drug Alcohol Abuse 2005, 31(4):571-591.
36. Pace-Schott E.F., Morgan P.T., Malison R.T., Hart C.L., Edgar C., Walker M., Stickgold R. Cocaine users differ from normals on cognitive tasks which show poorer performance during drug abstinence. Am. J. Drug Alcohol Abuse 2008, 34(1):109-121.
37. Perlstein W.M., Dixit N.K., Carter C.S., Noll D.C., Cohen J.D. Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia. Biol. Psychiatry 2003, 53(1):25-38.
38. Robins Wahlin T.B., Bäckman L., Wahlin A., Winblad B. Trail making test performance in a community-based sample of healthy very old adults: effects of age on completion time, but not on accuracy. Arch. Gerontol. Geriatr. 1996, 22(1):87-102.
39. Ryan J.J., Arb J.D., Paul C.A., Kreiner D.S. Reliability of the WAIS-III subtests, indexes, and IQs in individuals with substance abuse disorders. Assessment 2000, 7:151-156.
40. Sánchez-Cubillo I., Periáñez J.A., Adrover-Roig D., Rodríguez-Sánchez J.M., Ríos-Lago M., Tirapu J., Barceló F. Construct validity of the trail making test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. J. Int. Neuropsychol. Soc. 2009, 15(3):438-450.
41. Streeter C.C., Terhune D.B., Whitfield T.H., Gruber S., Sarid-Segal O., Silveri M.M., Tzilos G., Afshar M., Rouse E.D., Tian H., Renshaw P.F., Ciraulo D.A., Yurgelun-Todd D.A. Performance on the stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology 2008, 33:827-836.
42. Stuss D.T., Alexander M.P. Is there a dysexecutive syndrome?. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2007, 362(1481):901-915.
43. Suutama T., Ruoppila I., Stig B. Changes in cognitive functioning from 75 to 80 years of age: a 5-year follow-up in two Nordic localities. Aging Clin. Exp. Res. 2002, 14(Suppl. 3):29-36.
44. UNODC World Drug Report 2007, United Nations Publications.
45. Verdejo-García A., Pérez-García M. Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components. Psychopharmacology (Berl) 2007, 190:517-530.
46. Verdejo-García A.J., López-Torrecillas F., Aguilar de Arcos F., Pérez-García M. Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis. Addict. Behav. 2005, 30:89-101.
47. Walker R., Husain M., Hodgson T.L., Harrison J., Kennard C. Saccadic eye movement and working memory deficits following damage to human prefrontal cortex. Neuropsychologica 1998, 36(11):1141-1159.
48. Wilson B.A., Alderman N., Burgess P.W., Emslie H., Evans J.J. Behavioral assessment of the dysexecutive syndrome 1996, Thames Valley Test Company, Bury St. Edmunds, U.K.
49. Woicik P.A., Moeller S.J., Alia-Klein N., Maloney T., Lukasik T.M., Yeliosof O., Wang G.J., Volkow N.D., Goldstein R.Z. The neuropsychology of cocaine addiction: recent cocaine use masks impairment. Neuropsychopharmacology 2009, 34(5):1112-1122. Erratum in: Neuropsychopharmacology 34 (5), 1360.